Mito S, Miyajima M, Tomioka H, Sato H, Takeuchi T, Muto H, Kabasawa Y, Harada H, Eguchi K, Kato S, Kano M. Postoperative Delirium Prediction Based on Preoperative Electrocardiogram and Electroencephalogram 2024 Asia Pacific Signal and Information Processing Association Annual Summit and Conference (APSIPA ASC). 2024.12;
Noji R, Tohyama K, Nakamura S, Naito T, Oikawa Y, Kuroshima T, Tomioka H, Michi Y, Ikeda S, Asakage T, Miura N, Hamamoto Y, Harada H, Kano Y. Dynamic Changes in Circulating Tumor DNA During Immunotherapy for Head and Neck Cancer: SHIZUKU-HN Study International Journal of Molecular Sciences. 2024.12; 26(1); 235
Okuyama K, Yanamoto S. Saliva in Balancing Oral and Systemic Health, Oral Cancer, and Beyond: A Narrative Review Cancers. 2024.12; 16(24); 4276
Hirai H, Kinoshita N, Nishii N, Oikawa Y, Kugimoto T, Kuroshima T, Tomioka H, Michi Y, Sumita Y, Tomihara K, Harada H. Treatment strategies for patients over 80 years of age with oral squamous cell carcinoma. Surgical oncology. 2024.09; 57; 102146
Otsuru M, Yamakawa N, Kirita T, Yamada SI, Kurita H, Kugimoto T, Harada H, Hasegawa T, Akashi M, Takeshita A, Uzawa N, Umeda M, Yanamoto S, Yamada T. Efficacy and safety of molecularly targeted agents and immune checkpoint inhibitors for unresectable or recurrent/metastatic oral cancer in Japan JOURNAL OF DENTAL SCIENCES. 2024.07; 19(3); 1628-1637
Ibi H, Takahashi K, Harada H, Watabe T, Podyma-Inoue KA. Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis. Biochem Biophys Res Commun. 2024.06; 714; 149965
Kim CY, Takeshita Y, Kugimoto T, Harada H, Park JS, Tubbs RS, Iwanaga J. Anatomy of the Buccal Space: Surgical and Radiological Perspectives. The Journal of craniofacial surgery. 2024.06;
Yamaguchi K, Okumura T, Oikawa Y, Nakagawa K, Yoshimi K, Harada H, Tohara H. Effect of oral intake initiation-establishment interval on hospital stay after oral cancer surgery Oral Diseases. 2024.05;
Kuroshima T, Kitagawa Y, Sato J, Watanabe S, Asaka T, Abe T, Harada H, Hirata K, Kuge Y. Correction: Maximum standardized uptake value in (11)C-methionine positron emission tomography may predict the prognosis of patients with oral squamous cell carcinoma. Odontology. 2024.05;
Suenaga M, Yamauchi S, Morikawa R, Noji R, Kano Y, Tokunaga M, Kinugasa Y. Chemotherapy and COVID-19 Vaccination in Patients With Gastrointestinal Cancer in vivo. 2024.05; 38(3); 1278-1284
Iwasaki T, Harazono Y, Fukawa Y, Kaida A, Kayamori K, Sasaki Y, Harada H, Yoda T. Retrospective analysis of odontogenic myxoma and odontogenic myxofibroma in the oral and maxillofacial region: a fibrous tissue-related differentiation. The British journal of oral & maxillofacial surgery. 2024.02; 62; 464-470
Tomioka H, Nishii N, Oikawa Y, Kugimoto T, Kuroshima T, Hirai H; Kayamori K, Kaida A, Miura M, Harada H. Clinicopathological analysis of 134 patients with squamous cell carcinoma of the mandibular gingiva HELIYON. 2024.01; 10(1); e23120
Tokizaki S, Podyma-Inoue KA, Matsumoto T, Takahashi K, Kobayashi M, Ibi H, Uchida S, Iwabuchi S, Harada H, Hashimoto S, Miyazono K, Shirouzu M, Watabe T. Inhibition of transforming growth factorβ signals suppresses tumor formation by regulation of tumor microenvironment networks Cancer Science. 2024.01; 115(1); 211-226
Gong W, Taner HF, Wu Y, Li Z, Cheng W, Hu Q, Donnelly CR, Nor F, He Y, Zhai Z, Fitzsimonds ZR, Broses L, Li J, Bellile E, Okuyama K, Demehri S, Nagrath D, Wolf GT, Yu Y, Wen H, Wei L, Sikora AG, Chinn SB, Akira S, Xie Y, Moon JJ, Lei YL. Metabolic inhibition of BATF2 dampens type-I interferon-mediated immune sensing of cancer . Allison Institute Second Annual Scientific Symposium at UT MD Anderson Cancer Center 2024.10.10 Houston, Texas, USA
Oikawa Y, Kinoshita N, Nishii N, Shimizu R, Kugimoto T, Kuroshima T, Tomioka H, Michi Y, Harada H. Clinicopathological study of cervical lymph node metastasis in patients with oral tongue squamous cell carcinoma with depth of invasion ≦ 5 mm. KAOMS2024 2024.04.11 Seoul, Korea
Shimizu R, Kuroshima T, Nishii N, Oikawa Y, Kugimoto T, Tomioka T, Michi Y, Harada H. Clinico-pathological study on the double cancers of oral squamous cell carcinoma and malignant lymphoma. KAOMS2024 2024.04.11 Seoul, Korea
Kuroshima T, Michi Y, Harada H. Prognostic factors of squamous cell carcinoma arising in maxillary gingiva.. Taiwanese Association of Oral & Maxillofacial Surgeons The 36th Annual Congress on Oral and Maxillofacial Surgery 2024.03.10 台湾
Kuroshima T, Michi Y, Harada H. Surgical Treatment for Superficial Oral Cancer. Taiwanese Association of Oral & Maxillofacial Surgeons The 36th Annual Congress on Oral and Maxillofacial Surgery 2024.03.10 台湾
Michi Y, Kuroshima T,Harada H. Surgical Treatment of Superficial Oral Cancer. Taiwanese Association of Oral & Maxillofacial Surgeons The 36th Annual Congress on Oral and Maxillofacial Surgery 2024.03.10 台湾
Oikawa Y, Jie Y, Su Y, Nishii N, Noji R, Shimizu R, Kinoshita N, Kugimoto T, Kuroshima Y, Tomioka H, Michi Y, Azuma M, Harada H. A study of distant metastasis in patients with cT1-2N0 oral tongue squamous cell carcinoma. 第62回日本癌治療学会学術集会 2024.10.24 福岡市
Noji R, Tohyama K, Nakamura S, Naito T, Oikawa Y, Kuroshima T, Tomioka H, Michi Y, Miura M, Hamamoto Y, Harada H, Kano Y. Prospective Monitoring for Immunotherapy by Liquid Biopsy in Head and Neck Cancer. 第62回日本癌治療学会学術集会 2024.10.24 福岡市
Su Y, Ouchi R, Daroonpan P, Nishii N, Harada H, Ikeda T, Aida J, Azuma M. Personal immune profiles of oral tongue squamous cell carcinoma -Part 1: Analyses of 87 cases of surgical specimens and immune subtype classification-. The 1st International Symposium on Cancer Immunology and Immunotherapy 2024.03.23 札幌市
